These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 34422932)

  • 1. Dynamic Changes of Metabolic Syndrome Alter the Risks of Cardiovascular Diseases and All-Cause Mortality: Evidence From a Prospective Cohort Study.
    He D; Zhang X; Chen S; Dai C; Wu Q; Zhou Y; Jin Z; Wu S; Zhu Y
    Front Cardiovasc Med; 2021; 8():706999. PubMed ID: 34422932
    [No Abstract]   [Full Text] [Related]  

  • 2. Gender differences in changes in metabolic syndrome status and its components and risk of cardiovascular disease: a longitudinal cohort study.
    Ramezankhani A; Azizi F; Hadaegh F
    Cardiovasc Diabetol; 2022 Nov; 21(1):227. PubMed ID: 36324143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Age of Metabolic Syndrome Onset With Cardiovascular Diseases: The Kailuan Study.
    Huang Z; Wang X; Ding X; Cai Z; Li W; Chen Z; Fang W; Cai Z; Lan Y; Chen G; Wu W; Chen Z; Wu S; Chen Y
    Front Endocrinol (Lausanne); 2022; 13():857985. PubMed ID: 35370968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic syndrome vs. its components for prediction of cardiovascular mortality: A cohort study in Chinese elderly adults.
    Sun DL; Wang JH; Jiang B; Li LS; Li LS; Wu L; Wu HY; He Y
    J Geriatr Cardiol; 2012 Jun; 9(2):123-9. PubMed ID: 22916057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk for cardiovascular disease associated with metabolic syndrome and its components: a 13-year prospective study in the RIVANA cohort.
    Guembe MJ; Fernandez-Lazaro CI; Sayon-Orea C; Toledo E; Moreno-Iribas C;
    Cardiovasc Diabetol; 2020 Nov; 19(1):195. PubMed ID: 33222691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults.
    Malik S; Wong ND; Franklin SS; Kamath TV; L'Italien GJ; Pio JR; Williams GR
    Circulation; 2004 Sep; 110(10):1245-50. PubMed ID: 15326067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in frailty and incident cardiovascular disease in three prospective cohorts.
    He D; Wang Z; Li J; Yu K; He Y; He X; Liu Y; Li Y; Fu R; Zhou D; Zhu Y
    Eur Heart J; 2024 Mar; 45(12):1058-1068. PubMed ID: 38241094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between cumulative metabolic risk exposure and cardiovascular disease: a nationwide cohort of over 3.6 million young adults.
    Lee H; Rhee TM; Park HE; Han K; Choi SY
    Eur J Prev Cardiol; 2024 Aug; 31(10):1288-1300. PubMed ID: 38421612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modification of the all-cause and cardiovascular disease related mortality risk with changes in the metabolic syndrome status: a population-based prospective cohort study in Taiwan.
    Lai YJ; Yen YF; Chen LJ; Hsu LF; Ahmadi MN; Inan-Eroglu E; Ku PW; Stamatakis E
    Diabetes Metab; 2023 May; 49(3):101415. PubMed ID: 36563960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns.
    Wang J; Ruotsalainen S; Moilanen L; Lepistö P; Laakso M; Kuusisto J
    Eur Heart J; 2007 Apr; 28(7):857-64. PubMed ID: 17303589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triglyceride levels and risk of cardiovascular disease and all-cause mortality in Chinese adults younger than 40 years old: a prospective cohort study.
    Wu Z; Gao J; Chen S; Wang G; Liu H; Wang X; Sun P; Yu X; Yang Q; Wu S; Zhou X
    Cardiovasc Diagn Ther; 2024 Apr; 14(2):240-250. PubMed ID: 38716315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic Status of SII and SIRI Alters the Risk of Cardiovascular Diseases: Evidence from Kailuan Cohort Study.
    Li J; He D; Yu J; Chen S; Wu Q; Cheng Z; Wei Q; Xu Y; Zhu Y; Wu S
    J Inflamm Res; 2022; 15():5945-5957. PubMed ID: 36274831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex factors in the metabolic syndrome as a predictor of cardiovascular disease.
    Suh S; Baek J; Bae JC; Kim KN; Park MK; Kim DK; Cho NH; Lee MK
    Endocrinol Metab (Seoul); 2014 Dec; 29(4):522-9. PubMed ID: 25559575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of metabolic syndrome with risk of cardiovascular disease mortality and all-cause mortality among Malaysian adults: a retrospective cohort study.
    Chee Cheong K; Lim KH; Ghazali SM; Teh CH; Cheah YK; Baharudin A; Lim HL; Abdul Hamid AM; Mustapha FI; Omar MA
    BMJ Open; 2021 Aug; 11(8):e047849. PubMed ID: 34408040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maximal exercise electrocardiographic responses and coronary heart disease mortality among men with metabolic syndrome.
    Lyerly GW; Sui X; Church TS; Lavie CJ; Hand GA; Blair SN
    Mayo Clin Proc; 2010 Mar; 85(3):239-46. PubMed ID: 20160139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin d deficiency and metabolic syndrome: The joint effect on cardiovascular and all-cause mortality in the United States adults.
    Liu L; Cui S; Volpe SL; May NS; Sukumar D; DiMaria-Ghalili RA; Eisen HJ
    World J Cardiol; 2022 Jul; 14(7):411-426. PubMed ID: 36161059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Independent association between age- and sex-specific metabolic syndrome severity score and cardiovascular disease and mortality.
    Honarvar M; Mehran L; Masoumi S; Agahi S; Khalili S; Azizi F; Amouzegar A
    Sci Rep; 2023 Sep; 13(1):14621. PubMed ID: 37669997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lifetime risk of cardiovascular disease and life expectancy with and without cardiovascular disease according to changes in metabolic syndrome status.
    Li D; Wang L; Zhou Z; Song L; Chen S; Yang Y; Hu Y; Wang Y; Wu S; Tian Y
    Nutr Metab Cardiovasc Dis; 2022 Feb; 32(2):373-381. PubMed ID: 34893414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic interactions between cardiovascular risk factors.
    Vishram JK
    Dan Med J; 2014 Jul; 61(7):B4892. PubMed ID: 25123126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous metabolic syndrome severity score and the risk of CVD and all-cause mortality.
    Tang X; Wu M; Wu S; Tian Y
    Eur J Clin Invest; 2022 Sep; 52(9):e13817. PubMed ID: 35598176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.